Takashi Imada

This inventor holds 18 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc.. Active years: 1999-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Imada. Retrieved from https://idiyas.com/inventor/takashi-imada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 159(Granted Patents)

Location History:

Takarazuka, JP (2009)
Tsukuba, JP (1999 - 2012)
Osaka, JP (2007 - 2014)
Kanagawa, JP (2016 - 2018)
Fujisawa, JP (2016 - 2018)

Company Filing History:

14 out of 1,226

Takeda Pharmaceutical Company Limited

patents

4 out of 1,858

Takeda Chemical Industries, Inc.

patents

Years Active: 1999-2018

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10093629 - Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors (2018-10-09),

2. 10053468 - Heterocyclic compound (2018-08-21),

3. 10000488 - Heterocyclic compound (2018-06-19),

4. 9650343 - Heterocyclic compound (2017-05-16),

5. 9630924 - Heterocyclic compound (2017-04-25),

6. 9573903 - Heterocyclic compound (2017-02-21),

7. 9365520 - Heterocyclic compound (2016-06-14),

8. 9346822 - Thienopyrimidine compounds and use thereof (2016-05-24),

9. 8735401 - Thienopyrimidine compounds and use thereof (2014-05-27),

10. 8324395 - Heterocyclic compound and use thereof (2012-12-04),

11. 8058280 - Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof (2011-11-15),

12. 7622479 - Bicyclic derivative, its production and use (2009-11-24),

13. 7569570 - Thienopyrimidines, process for preparing the same and use thereof (2009-08-04),

14. 7300935 - Thienopyrimidine compounds and use thereof (2007-11-27),

15. 6329388 - Thienopyridine compounds, their production and use (2001-12-11),

Title: The Innovations of Takashi Imada: A Pioneer in Heterocyclic Compounds

Introduction

Takashi Imada, an accomplished inventor based in Kanagawa, Japan, has made significant contributions to the field of chemistry with a remarkable portfolio of 18 patents. His innovative work primarily focuses on heterocyclic compounds, which have critical applications in the pharmaceutical industry.

Latest Patents

Among Imada's notable recent patents is the invention concerning "Heterocyclic Compounds and Their Use as Retinoid-Related Orphan Receptor (ROR) Gamma-T Inhibitors." This invention encompasses a variety of heterocyclic compounds represented by a specific formula, demonstrating a RORγt inhibitory action. The compounds hold potential for therapeutic applications, particularly in modulating immune responses.

Career Highlights

Imada's professional journey is marked by his tenure at Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His work within these prestigious organizations has allowed him to advance his research and contribute to groundbreaking developments in medicinal chemistry.

Collaborations

Throughout his career, Takashi Imada has collaborated with esteemed colleagues, including Nobuhiro Suzuki and Tsuneo Oda. These partnerships have further enhanced the scope and impact of his research, fostering an environment of innovation and excellence in the realm of pharmaceuticals.

Conclusion

With his extensive experience and innovative spirit, Takashi Imada continues to be a driving force in the development of heterocyclic compounds. His contributions not only reflect his dedication as an inventor but also underscore the significant role that such innovations play in advancing pharmaceutical science.

Profile summary based on public USPTO records.